S Graff-Iversen1, R Selmer, M-L Løchen. 1. Norwegian Institute of Public Health, Marcus Thranesgate 6, Box 4404 Nydalen, NO-0403 Oslo. sgri@fhi.no
Abstract
OBJECTIVE: To determine the long-term coronary heart disease (CHD) mortality in women and men with symptoms, according to the Rose Angina Questionnaire at a relatively young age. DESIGN: Cohort study with the baseline survey conducted during 1974-8. Information on symptoms was collected by a short, three-item version of the Rose Angina Questionnaire. Participants were re-invited to a similar survey five years later and followed for mortality throughout 2000. SETTING: Three counties in Norway (the Norwegian Counties Study). PARTICIPANTS: 16 616 men and 16 265 women aged 40-49 years and denying CHD in 1974-8. MAIN OUTCOME MEASURE: CHD mortality during 23 years. RESULTS: By the end of follow-up 1316 men (7.9%) and 310 women (1.9%) had died from CHD, including 16% (66/406) of men and 4% (24/563) of women with Rose angina in 1974-8. Rose angina implied an elevated mortality from CHD with adjusted hazard ratios 1.50 (95% CI 1.16 to 1.93) in men and 1.98 (95% CI 1.30 to 3.02) in women. According to calculations based on the Cox model these increases in risk are similar to those associated with elevations of total cholesterol by 1.8 mmol/l (men) and 2.5 mmol/l (women) or elevations of systolic blood pressure by 21 mm Hg (men) or 31 mm Hg (women). CONCLUSIONS: Angina symptoms in ages as low as 40-49 years were associated with elevated long-term CHD mortality in Norwegian women and men. This indicates that the three-item version of the Rose Angina Questionnaire, although a screening tool rather than a diagnostic test, adds information on undiagnosed CHD in both sexes.
OBJECTIVE: To determine the long-term coronary heart disease (CHD) mortality in women and men with symptoms, according to the Rose Angina Questionnaire at a relatively young age. DESIGN: Cohort study with the baseline survey conducted during 1974-8. Information on symptoms was collected by a short, three-item version of the Rose Angina Questionnaire. Participants were re-invited to a similar survey five years later and followed for mortality throughout 2000. SETTING: Three counties in Norway (the Norwegian Counties Study). PARTICIPANTS: 16 616 men and 16 265 women aged 40-49 years and denying CHD in 1974-8. MAIN OUTCOME MEASURE: CHD mortality during 23 years. RESULTS: By the end of follow-up 1316 men (7.9%) and 310 women (1.9%) had died from CHD, including 16% (66/406) of men and 4% (24/563) of women with Rose angina in 1974-8. Rose angina implied an elevated mortality from CHD with adjusted hazard ratios 1.50 (95% CI 1.16 to 1.93) in men and 1.98 (95% CI 1.30 to 3.02) in women. According to calculations based on the Cox model these increases in risk are similar to those associated with elevations of total cholesterol by 1.8 mmol/l (men) and 2.5 mmol/l (women) or elevations of systolic blood pressure by 21 mm Hg (men) or 31 mm Hg (women). CONCLUSIONS:Angina symptoms in ages as low as 40-49 years were associated with elevated long-term CHD mortality in Norwegian women and men. This indicates that the three-item version of the Rose Angina Questionnaire, although a screening tool rather than a diagnostic test, adds information on undiagnosed CHD in both sexes.
Authors: M J S Zaman; M J Shipley; M Stafford; E J Brunner; A D Timmis; M G Marmot; H Hemingway Journal: J Public Health (Oxf) Date: 2010-11-02 Impact factor: 2.341
Authors: Adrian Loerbroks; Jos Antonio Bosch; Paula Maria Christina Mommersteeg; Raphael Manfred Herr; Peter Angerer; Jian Li Journal: Eur J Epidemiol Date: 2014-06-22 Impact factor: 8.082
Authors: Muhammad Aziz Rahman; Nicola Spurrier; Mohammad Afzal Mahmood; Mahmudur Rahman; Sohel Reza Choudhury; Stephen Leeder Journal: Indian Heart J Date: 2012-09-12
Authors: E R Zakiev; V N Sukhorukov; A A Melnichenko; I A Sobenin; E A Ivanova; A N Orekhov Journal: Lipids Health Dis Date: 2016-08-24 Impact factor: 3.876
Authors: Emile R Zakiev; Igor A Sobenin; Vasily N Sukhorukov; Veronika A Myasoedova; Ekaterina A Ivanova; Alexander N Orekhov Journal: Vasc Health Risk Manag Date: 2016-10-14
Authors: Grace Sum; Gerald Choon-Huat Koh; Stewart W Mercer; Lim Yee Wei; Azeem Majeed; Brian Oldenburg; John Tayu Lee Journal: BMC Public Health Date: 2020-01-06 Impact factor: 3.295